Diflucortolone Valerate/Lidocaine

戊酸二氟可龙/利多卡因

Report date: 2026/02/13 10:40:21
NME

Base Information

Drug NameDiflucortolone Valerate/Lidocaine
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor agonistsSodium channel alpha subunit modulators
TargetsGlucocorticoid receptorSodium channel alpha subunit
Therapy Area/IndicationsPainHemorrhoidsProctitis
Global Approved IndicationsHemorrhoids
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryEUJapan
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPainHemorrhoidsProctitis
Inactive IndicationsN/A

Other Information

ATC CodeC05AA08D07AC05D07XC05 +[4
Related LinksN/A